Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants

Published:2022-03-30 Issue:1 Volume:11 Page:926-937
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Zhao Hanjun¹²³^ORCID,Meng Xinjie²,Peng Zheng²,Lam Hoiyan²,Zhang Chuyuan²,Zhou Xinxin²,Chan Jasper Fuk-Woo¹²³⁴⁵^ORCID,Kao Richard Yi Tsun¹²³,To Kelvin Kai-Wang¹²³⁴⁵^ORCID,Yuen Kwok-Yung¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China

2. Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China

3. Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People’s Republic of China

4. Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China

5. Guangzhou Laboratory, Guangzhou Province, China

Funder

Richard Yu and Carol Yu

Michael Seak-Kan Tong

May Tam Mak Mei Yin

Shaw Foundation Hong Kong

Respiratory Viral Research Foundation Limited

Hui Ming

Hui Hoy

Chow Sin Lan Charity Fund

Chan Yin Chuen Memorial Charitable Foundation

Marina Man-Wai Lee

Health@InnoHK

Centre for Virology, Vaccinology and Therapeutics

Innovation and Technology Commission

Health and Medical Research Fund

Food and Health Bureau

Government of the Hong Kong

National Program on Key Research Project of China

National Key R&D Program of China

National Natural Science Foundation of China

Anhui Provincial Key Laboratory of Molecular Enzymology and Mechanism of Major Diseases

Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2051753

Reference45 articles.

1. Influenza: lessons from past pandemics, warnings from current incidents

2. Pandemic potential of avian influenza A (H7N9) viruses

3. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza

4. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

5. Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the main SARS-Cov-2 pathways with peptide inhibitors by molecular docking and molecular simulation approaches;Journal of Molecular Liquids;2024-02

2. SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication;Journal of Clinical Medicine;2023-09-20

3. Long-term effects of SARS-CoV-2 infection on human brain and memory;Cell Death Discovery;2023-06-29

4. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo;PLOS Pathogens;2023-05-01

5. Broad-Spectrum Antivirals Derived from Natural Products;Viruses;2023-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3